JP2019529560A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019529560A5 JP2019529560A5 JP2019537047A JP2019537047A JP2019529560A5 JP 2019529560 A5 JP2019529560 A5 JP 2019529560A5 JP 2019537047 A JP2019537047 A JP 2019537047A JP 2019537047 A JP2019537047 A JP 2019537047A JP 2019529560 A5 JP2019529560 A5 JP 2019529560A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- inhibitor
- patient
- csa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022128592A JP2022160685A (ja) | 2016-09-22 | 2022-08-12 | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 |
| JP2024153668A JP2024174962A (ja) | 2016-09-22 | 2024-09-06 | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 |
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662397988P | 2016-09-22 | 2016-09-22 | |
| US62/397,988 | 2016-09-22 | ||
| US201762442083P | 2017-01-04 | 2017-01-04 | |
| US62/442,083 | 2017-01-04 | ||
| US201762443819P | 2017-01-09 | 2017-01-09 | |
| US62/443,819 | 2017-01-09 | ||
| US201762445774P | 2017-01-13 | 2017-01-13 | |
| US62/445,774 | 2017-01-13 | ||
| US201762519896P | 2017-06-15 | 2017-06-15 | |
| US62/519,896 | 2017-06-15 | ||
| EP17306081.5 | 2017-08-18 | ||
| EP17306081 | 2017-08-18 | ||
| PCT/US2017/052772 WO2018057776A1 (en) | 2016-09-22 | 2017-09-21 | Methods for treating severe atopic dermatitis by administering an il-4r inhibitor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022128592A Division JP2022160685A (ja) | 2016-09-22 | 2022-08-12 | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019529560A JP2019529560A (ja) | 2019-10-17 |
| JP2019529560A5 true JP2019529560A5 (2) | 2020-10-22 |
| JP7164530B2 JP7164530B2 (ja) | 2022-11-01 |
Family
ID=59974890
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019537047A Active JP7164530B2 (ja) | 2016-09-22 | 2017-09-21 | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 |
| JP2022128592A Pending JP2022160685A (ja) | 2016-09-22 | 2022-08-12 | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 |
| JP2024153668A Pending JP2024174962A (ja) | 2016-09-22 | 2024-09-06 | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022128592A Pending JP2022160685A (ja) | 2016-09-22 | 2022-08-12 | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 |
| JP2024153668A Pending JP2024174962A (ja) | 2016-09-22 | 2024-09-06 | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220110999A1 (2) |
| EP (2) | EP4345110A3 (2) |
| JP (3) | JP7164530B2 (2) |
| KR (3) | KR20190053250A (2) |
| CN (2) | CN118203659A (2) |
| AU (2) | AU2017332732B2 (2) |
| CA (1) | CA3037499A1 (2) |
| ES (1) | ES2974376T3 (2) |
| HU (1) | HUE066662T2 (2) |
| IL (2) | IL265516B2 (2) |
| MX (3) | MX2019003235A (2) |
| PL (1) | PL3515465T3 (2) |
| RU (1) | RU2759630C2 (2) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| PT3889181T (pt) | 2012-09-07 | 2024-05-29 | Regeneron Pharma | Um anticorpo antagonista de il-4r para utilização no tratamento da dermatite atópica por administração |
| TWI633891B (zh) | 2013-06-04 | 2018-09-01 | 再生元醫藥公司 | 藉由投與ｉｌ－４ｒ抑制劑以治療過敏及增強過敏原－特異之免疫療法的方法 |
| TWI682781B (zh) | 2013-07-11 | 2020-01-21 | 美商再生元醫藥公司 | 藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法 |
| WO2015130975A1 (en) | 2014-02-28 | 2015-09-03 | Regeneron Pharmaceuticals, Inc. | Methods for treating skin infection by administering an il-4r antagonist |
| HUE067888T2 (hu) | 2016-09-01 | 2024-11-28 | Regeneron Pharma | Módszerek az allergia megelõzésére vagy kezelésére egy IL-4R antagonista adagolásával |
| CN110746507B (zh) * | 2018-12-25 | 2020-06-26 | 江苏荃信生物医药有限公司 | 抗人白介素4受体α单克隆抗体及其应用 |
| CA3132587A1 (en) | 2019-03-21 | 2020-09-24 | Regeneron Pharmaceuticals, Inc. | Combination of il-4/il-13 pathway inhibitors and plasma cell ablation for treating allergy |
| WO2021026205A1 (en) | 2019-08-05 | 2021-02-11 | Regeneron Pharmaceuticals, Inc. | Methods for treating atopic dermatitis by administering an il-4r antagonist |
| US11504426B2 (en) | 2019-08-05 | 2022-11-22 | Regeneron Pharmaceuticals, Inc. | Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist |
| WO2022155404A1 (en) * | 2021-01-14 | 2022-07-21 | Translate Bio, Inc. | Methods and compositions for delivering mrna coded antibodies |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2990420T3 (en) | 2000-05-26 | 2017-04-03 | Immunex Corp | USE OF INTERLEUKIN-4 RECEPTOR ANTIBODIES AND COMPOSITIONS THEREOF |
| EP1351704B1 (en) * | 2000-12-21 | 2007-03-07 | Nektar Therapeutics | Storage stable powder compositions of interleukin-4 receptor |
| BRPI0416603A (pt) | 2003-11-07 | 2007-01-30 | Immunex Corp | anticorpo que se liga ao receptor interleucina-4 (il-4) humano |
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| MY149079A (en) | 2006-10-02 | 2013-07-15 | Regeneron Pharma | High affinity human antibodies to human il-4 receptor |
| US8092804B2 (en) | 2007-12-21 | 2012-01-10 | Medimmune Limited | Binding members for interleukin-4 receptor alpha (IL-4Rα)-173 |
| NZ609557A (en) | 2010-10-06 | 2014-12-24 | Regeneron Pharma | Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies |
| PT3889181T (pt) | 2012-09-07 | 2024-05-29 | Regeneron Pharma | Um anticorpo antagonista de il-4r para utilização no tratamento da dermatite atópica por administração |
| TWI682781B (zh) * | 2013-07-11 | 2020-01-21 | 美商再生元醫藥公司 | 藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法 |
| IL315136A (en) | 2014-02-21 | 2024-10-01 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an il-4rantagonist |
| WO2018057776A1 (en) | 2016-09-22 | 2018-03-29 | Regeneron Pharmaceuticals, Inc. | Methods for treating severe atopic dermatitis by administering an il-4r inhibitor |
-
2017
- 2017-09-21 EP EP23216251.1A patent/EP4345110A3/en active Pending
- 2017-09-21 KR KR1020197011455A patent/KR20190053250A/ko not_active Ceased
- 2017-09-21 ES ES17777145T patent/ES2974376T3/es active Active
- 2017-09-21 CA CA3037499A patent/CA3037499A1/en active Pending
- 2017-09-21 CN CN202410243081.1A patent/CN118203659A/zh active Pending
- 2017-09-21 JP JP2019537047A patent/JP7164530B2/ja active Active
- 2017-09-21 CN CN201780071612.1A patent/CN109963577B/zh active Active
- 2017-09-21 KR KR1020247032347A patent/KR20240146104A/ko active Pending
- 2017-09-21 AU AU2017332732A patent/AU2017332732B2/en active Active
- 2017-09-21 RU RU2019111921A patent/RU2759630C2/ru active
- 2017-09-21 HU HUE17777145A patent/HUE066662T2/hu unknown
- 2017-09-21 EP EP17777145.8A patent/EP3515465B1/en active Active
- 2017-09-21 KR KR1020227045686A patent/KR20230006049A/ko not_active Ceased
- 2017-09-21 PL PL17777145.8T patent/PL3515465T3/pl unknown
- 2017-09-21 MX MX2019003235A patent/MX2019003235A/es unknown
- 2017-09-21 IL IL265516A patent/IL265516B2/en unknown
- 2017-09-21 IL IL310371A patent/IL310371A/en unknown
-
2019
- 2019-03-21 MX MX2024011262A patent/MX2024011262A/es unknown
- 2019-03-21 MX MX2023014187A patent/MX2023014187A/es unknown
-
2021
- 2021-09-22 US US17/482,273 patent/US20220110999A1/en active Pending
-
2022
- 2022-08-12 JP JP2022128592A patent/JP2022160685A/ja active Pending
-
2024
- 2024-06-11 AU AU2024203951A patent/AU2024203951A1/en active Pending
- 2024-09-06 JP JP2024153668A patent/JP2024174962A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019529560A5 (2) | ||
| JP2025172841A5 (2) | ||
| JP2022543612A5 (2) | ||
| RU2019111921A (ru) | Способы лечения тяжелого атопического дерматита путем введения ингибитора il-4r | |
| JP2022160685A5 (2) | ||
| CN106062000B (zh) | 通过施用il-4r拮抗剂治疗皮肤感染的方法 | |
| JP2021523188A5 (2) | ||
| RU2016136364A (ru) | Способы лечения или предупреждения астмы посредством введения антагониста il-4r | |
| HRP20181227T1 (hr) | Metode za liječenje atopijskog dermatitisa primjenom antagonista il-4r | |
| JP2023520676A5 (2) | ||
| RU2019103943A (ru) | Применение антагонистов il-13 для лечения атопического дерматита | |
| JP2017507139A5 (2) | ||
| JP2024174962A5 (2) | ||
| CN112153982A (zh) | 用于通过施用il-4r抑制剂治疗特应性皮炎的方法 | |
| JP2016523863A5 (2) | ||
| JP2017512193A5 (2) | ||
| EP3487881B1 (en) | Methods of treating new-onset plaque type psoriasis using il-17 antagonists | |
| JP2024532263A5 (2) | ||
| Choy et al. | Mepolizumab (Nucala) for severe eosinophilic asthma | |
| JP2024530954A5 (2) | ||
| TW202045537A (zh) | 化膿性汗腺炎的治療 | |
| JP2025501239A5 (2) | ||
| Rommer et al. | Repurposing multiple sclerosis drugs: a review of studies in neurological and psychiatric conditions | |
| JP2022513029A5 (2) | ||
| HRP20191709T1 (hr) | Postupci liječenja nosne polipoze davanjem antagonista il-4r |